Gamma Biologicals Inc., Immucor deal

BLUD made a cash tender offer to acquire GBL for $5.40 per share, about $25 million. GBL, a manufacturer of in vitro diagnostic reagents for blood serology, will operate as a wholly owned subsidiary o...